DIABETES Unravelling the enigma of T2DM and cardiovascular disease

被引：3
|
作者：
Bowden, Donald W. [1 ]
Cox, Amanda J. [2 ,3 ]
机构：
[1] Wake Forest Sch Med, Ctr Genom & Personalized Med Res, Winston Salem, NC 27104 USA
[2] Griffith Univ, Griffith Hlth Inst, Southport, Qld 4215, Australia
[3] Griffith Univ, Sch Med Sci, Southport, Qld 4215, Australia
来源：
NATURE REVIEWS ENDOCRINOLOGY | 2013年 / 9卷 / 11期
关键词：
CORONARY-HEART-DISEASE;
D O I：
10.1038/nrendo.2013.192
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The association of type 2 diabetes mellitus with an increased risk of cardiovascular disease has been extensively documented, but the origins of this association remain largely in the realm of hypotheses. With surprisingly few insights into mechanisms of increased cardiovascular disease risk, efforts to shed new light on this important question are welcome.
引用
收藏
页码：632 / 633
页数：3
相关论文
共 50 条
  • [1] Unravelling the enigma of T2DM and cardiovascular disease
    Donald W. Bowden
    Amanda J. Cox
    [J]. Nature Reviews Endocrinology, 2013, 9 : 632 - 633
  • [2] Risk of cardiovascular disease in patients with T2DM
    [J]. Nature Reviews Endocrinology, 2013, 9 (6) : 316 - 316
  • [3] Preptin as a Potential Marker in Iraqi Newly Diagnosed T2DM and T2DM with Cardiovascular Disease
    Tahir, Noor Thair
    Al-Khateeb, Shatha M. J.
    Akram, Raghda Shams
    [J]. JOURNAL OF CONTEMPORARY MEDICAL SCIENCES, 2024, 10 (02): : 102 - 105
  • [4] Therapeutic Intensification Strategy and Incident Cardiovascular Disease (CVD) in Type 2 Diabetes Mellitus (T2DM)
    Korytkowski, Mary T.
    Brooks, Maria M.
    Orchard, Trevor J.
    Dealmeida, Dilhari
    Lombardero, Manuel
    Kanter, Justin
    Siminerio, Linda M.
    [J]. DIABETES, 2014, 63 : A118 - A118
  • [5] Association of cardiovascular disease prevalence with BMD and fracture in men with T2DM
    Kong, Xiao-ke
    Xie, Rui
    Zhang, Deng
    Chen, Xiao-jing
    Wang, Xiao-feng
    Lu, Jie-li
    Zhao, Hong-yan
    Liu, Jian-min
    Sun, Li-hao
    Tao, Bei
    [J]. JOURNAL OF DIABETES, 2024, 16 (04)
  • [6] Efficacy and Tolerability of Saxagliptin (SAXA) in Patients With Type 2 Diabetes Mellitus (T2DM) and a History of Cardiovascular Disease (CVD)
    Minervini, Gianmaria
    Cook, William
    Allen, Elsie
    [J]. DIABETES, 2013, 62 : A306 - A306
  • [7] The Association between Dynamic Changes of Metabolic Syndrome and Type 2 Diabetes Mellitus (T2DM) or Cardiovascular Disease (CVD)
    Yang, C.
    Guo, Z. R.
    Hu, X. S.
    Zhou, Z. Y.
    Wu, M.
    Yu, H.
    Zhang, L. J.
    Luo, W. S.
    Liu, J. C.
    [J]. CARDIOLOGY, 2010, 117 : 119 - 120
  • [8] DIABETES Peripheral Aβ linked to pathogenesis of T2DM
    Morris, Alan
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2017, 13 (10) : 564 - 564
  • [9] Immunogenicity, Safety, and Efficacy of Influenza Vaccine in T2DM and T2DM with Chronic Kidney Disease
    Heryaman, Henhen
    Juli, Cep
    Nazir, Arnengsih
    Syamsunarno, Mas Rizky A. A.
    Yahaya, Badrul Hisham
    Turbawaty, Dewi Kartika
    Sari, Rini Mulia
    Permana, Hikmat
    Supriyadi, Rudi
    Atik, Nur
    [J]. VACCINES, 2024, 12 (03)
  • [10] Cardiovascular safety of dapagliflozin in type 2 diabetes mellitus (T2DM) patients with various degrees of cardiovascular risk
    Sonesson, C.
    Frederich, R.
    Johansson, P. A.
    Gause-Nilsson, I.
    Langkilde, A. M.
    List, J. F.
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 : 1072 - 1072
12345